Health in 2 Point 00 Aug 28, 2020• With 3 consecutive days of $ 100M in funding, here is the most confusing (or rather the most confused we have been) Episode 147 of Health in 2 Point 00. Jess asks me about Verily partnering with Swiss Re to get into the stop-loss insurance game, Prescryptive… Read More »
FDA Approves Winlevi (clascoterone) Cream for the Treatment of Acne Print this page Lainate, Italy – August 27, 2020 – Cassiopea SpA (SIX: SKIN), today announced that the United States Food and Drug Administration (FDA) approved Winlevi (clascoterone cream 1%) for the treatment of acne in patients 12 years and older. Notwithstanding acne being the… Read More »
AstraZeneca put the rest of the SGLT2 inhibitor class on notice when its Farxiga scored an FDA heart failure nod in patients with or without diabetes. One of its competitors, Eli Lilly and Boehringer Ingelheim’s Jardiance, is fast on Farxiga’s heels, though, and it’s ready to bring its pivotal trial win in front of physicians. Jardiance, added… Read More »
FRIDAY, Aug. 28, 2020 — On the final night of the 2020 Democratic National Convention, the world heard from an improbable source — a 13-year-old named Brayden Harrington. Brayden was invited to speak because he has a frustrating and misunderstood condition that millions of Americans share, including Democratic presidential hopeful Joe Biden. “We stutter,” he… Read More »